According to The Deal’s recent interview with Dr. Matt Higgins, Management Professor at Georgia Institute of Technology, big pharma’s need to acquire new technology is increasing. He explains that expanded competition from generics and internal productivity issues with research not pumping out as many new drugs are to blame. What could potentially be viewed as […]

Read Full Post »

World TB Day is less than a week away on March 24th, so I though this would be a good opportunity to discuss the current state of Tuberculosis and what Nutra Pharma is doing to help those affected by it.
Before I began at Nutra Pharma in 2002, I thought Tuberculosis was a disease of the […]

Read Full Post »